SCHEMBL6622116

SCHEMBL6622116

CC(=O)N(CCc1ccccc1)N1CCNCC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.48
SIGMAR1 Q99720 3/20 0.44
CETP P11597 1/20 0.42
NAPEPLD Q6IQ20 1/20 0.41
HTR2C P28335 1/20 0.41
SLC6A4 P31645 2/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A3 Q01959 1/20 0.40
HTR6 P50406 1/20 0.40
ALDH1A1 P00352 2/20 0.40
USP2 O75604 1/20 0.39
TSHR P16473 1/20 0.39
HSD17B10 Q99714 1/20 0.39
OPRM1 P35372 2/20 0.39
PKM P14618 1/20 0.39
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
HTR3A P46098 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14938330 0.78 SIGMAR1 (0.39) KMT2ASIGMAR1CETPNAPEPLDHTR2C
SCHEMBL28856183 0.75 SIGMAR1 (0.34) KMT2ASIGMAR1MEN1
SCHEMBL29144839 0.74 SIGMAR1 (0.44) KMT2ASIGMAR1HTR2CSLC6A4SLC6A2
Acetic Acid SCHEMBL27373593 0.73 SIGMAR1 (0.66) KMT2ASIGMAR1SLC6A4SLC6A3OPRM1
SCHEMBL5521576 0.72 MEN1 (0.41) KMT2ASIGMAR1MEN1
SCHEMBL28199273 0.72 SIGMAR1 (0.36) SIGMAR1
SCHEMBL20897791 0.71 MGLL (0.62) KMT2ASIGMAR1MEN1
SCHEMBL5717885 0.71 SIGMAR1 (0.45) KMT2ASIGMAR1HTR2CHTR6ALDH1A1
SCHEMBL9690903 0.71 CHRM2 (0.51) HTR6ALDH1A1NPC1RAB9ATDP1
SCHEMBL27332317 0.71 NPC1 (0.46) KMT2ASIGMAR1SLC6A3ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1434763-A2 BETA-LACTAMYL VASOPRESSIN V1A ANTAGONISTS Serenix Pharmaceuticals, LLC (US) 2004-07-07 EP disclosed
WO-2003031407-A2 β-LACTAMYL VASOPRESSIN VlaANTAGONISTS SERENIX PHARMACEUTICALS, LLC (US) 2003-04-17 WO disclosed